BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• First Patient Treated With RayStation at India’s First Proton Center

  Apollo Proton Cancer Centre at Apollo Hospitals in Chennai, India, is the first proton therapy center to be established in India and it has successfully conducted its first patient treatment.

  February 6, 2019

   · 

  4 min read
• FDA

  Current Health Receives FDA Clearance for its Remote Patient Monitoring Solution, Enables Earlier Intervention and Improved Patient Outcomes

  The company will demonstrate its wireless wearable, which monitors vital signs with ICU-level accuracy and delivers patient-specific alerts and treatment recommendations, at HIMSS19

  February 6, 2019

   · 

  4 min read
• Business

  Elanco Animal Health Reports Strong 2018 Fourth Quarter and Full Year Results, Confirms 2019 Guidance

  Full year global revenue increased 6 percent to $3.1 billion, Interceptor® Plus reaches blockbuster status with more than $100 million in annual sales

  February 6, 2019

   · 

  27 min read
• Business

  Boston Scientific Announces Results For Fourth Quarter And Full Year 2018

  Boston Scientific Corporation generated sales of $2.561 billion during the fourth quarter of 2018.

  February 6, 2019

   · 

  24 min read
• Business

  Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

  Regeneron Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year 2018 and provided a business update.

  February 6, 2019

   · 

  29 min read
• Deals

  CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference

  CASI Pharmaceuticals, Inc. announces it will present at the BIO CEO & Investor Conference being held February 11-12, 2019 in New York City, New York.

  February 6, 2019

   · 

  4 min read
• Deals

  Exicure to Present at BIO CEO & Investor Conference 2019

  Exicure, Inc. announced that its CEO, Dr. David Giljohann, will present a corporate update on Monday, February 11, 2019 at 11:15 am EST at the BIO CEO & Investor Conference.

  February 6, 2019

   · 

  3 min read
• Pharm Country

  Kleo Pharmaceuticals to Present at 2019 BIO CEO & Investor Conference in New York City

  Kleo Pharmaceuticals Inc. announced that its Chief Executive Officer Douglas J. Manion, M.D., FRCP(C), will present at the BIO CEO & Investor Conference to be held February 11-12, 2019, at the Marriott Marquis in New York’s Time Square.

  February 6, 2019

   · 

  3 min read
• Drug Development

  Medicenna Shows Promising Pre-Clinical Results in Solid Tumor Models with its IL-2 Superkine, MDNA109

  Magnified IL-2 affinity towards CD122 potently synergizes with checkpoint inhibitors

  February 6, 2019

   · 

  6 min read
• Deals

  Australis Capital Commences Trading on the OTCQB Market in the United States

  Australis Capital Inc. is pleased to announce that the Company’s common shares have commenced trading on the OTCQB® Venture Market under the ticker symbol “AUSAF”.

  February 6, 2019

   · 

  4 min read